| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 26.5× | 27.6× | |
| Price / Book | 0.6× | 3.1× | |
| Price / Sales | 0.2× | 3.0× | |
| Price / Free cash flow | −5.2× | 1.0× | |
| EV / EBITDA | 4.3× | 17.3× | |
| Earnings yield | 3.8% | 2.4% | |
| Free cash flow yield | −19.2% | 0.0% | — |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
| ₹1,743.00 |
| −0.90% |
| $44.43B |
| 36.8× |
| 13.7% |
| +2.6% |
DINSE:DIVISLABDivi's Laboratories Ltd · 🇮🇳 NSE | ₹9,087.00 | −0.63% | $25.75B | 95.3× | 15.3% | +37.8% |
TONSE:TORNTPHARMTorrent Pharmaceuticals Ltd · 🇮🇳 NSE | ₹4,558.70 | +0.00% | $18.25B | 80.2× | 25.8% | +27.3% |
APNSE:APOLLOHOSPApollo Hospitals Enterprise Ltd · 🇮🇳 NSE | ₹7,700.00 | −2.41% | $11.95B | 58.5× | 20.5% | −1.8% |
ZYNSE:ZYDUSLIFEZydus Lifesciences Ltd · 🇮🇳 NSE | ₹1,113.90 | −0.81% | $11.8B | 22.3× | 18.6% | +10.8% |
LANSE:LAURUSLABSLaurus Labs Ltd · 🇮🇳 NSE | ₹2,069.00 | +0.43% | $11.7B | 125.2× | 16.8% | +121.4% |
CINSE:CIPLACipla Ltd · 🇮🇳 NSE | ₹1,324.10 | −0.08% | $11.26B | 27.6× | 11.3% | −16.4% |
DRNSE:DRREDDYDr Reddy's Laboratories Ltd · 🇮🇳 NSE | ₹1,242.50 | +0.77% | $10.81B | 24.0× | 11.4% | −2.9% |
AUNSE:AUROPHARMAAurobindo Pharma Ltd · 🇮🇳 NSE | ₹1,621.40 | −2.73% | $10.05B | 27.3× | 9.2% | +47.3% |
MANSE:MANKINDMankind Pharma Ltd · 🇮🇳 NSE | ₹2,253.20 | −0.98% | $9.89B | 49.1× | 11.7% | −7.9% |
